Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 1998 Jan 5;47(6):1275–1295. doi: 10.1016/S0093-691X(97)00107-6

Equine arteritis virus

AL Glaser 1, ED Chirnside 2,a, MC Horzinek 1, AAF de Vries 1
PMCID: PMC7127492  PMID: 16728076

Abstract

Equine arteritis virus (EAV) is a small, enveloped, positive-stranded RNA virus, in the family Arteriviridae, W.H.ich can infect both horses and donkeys. While the majority of EAV infections are asymptomatic, acutely infected animals may develop a wide range of clinical signs, including pyrexia, limb and ventral edema, depression, rhinitis, and conjunctivitis. The virus may cause abortion and has caused mortality in neonates. After natural EAV infection, most horses develop a solid, long-term immunity to the disease. Marzz and geldings eliminate the virus within 60 days, but 30 to 60% of acutely infected stallions will become persistently infected. These persistently infected animals maintain EAV within the reproductive tract, shed virus continuously in the semen, and can transmit the virus venereally. Mares infected venereally may not have clinical signs, but they shed large amounts of virus in nasopharyngeal secretions and in urine, which may result in lateral spread of the infection by an aerosol route. The consequences of venereally acquired infection are minimal, with no known effects on conception rate, but mares infected at a late stages of gestation may abort. Identification of carrier stallions is crucial to control the dissemination of EAV. The stallions can be identified by serological screening using a virus neutralization (VN) test. If positive at a titer of ≥ 1:4, the stallion should be tested for persistent infection by virus isolation from the sperm-rich fraction of the ejaculate, or by test mating Shedding stallions should not be used for breeding, or should be bred only to mares seropositive from a natural infection or from vaccination, the mares should be subsequently isolated from seronegative horses for three weeks after natural or artificial insemination. A live attenuated (ARVAC) and a formalin-inactivated (ARTERVAC) vaccine are available. Both vaccines induce virus-neutralizing antibodies, the presence of which correlates with protection from disease, abortion, and the development of a persistent infection. Serological investigations indicate that EAV has a worldwide distribution and that its prevalence is increasing. As a consequence, an increasing number of equine viral arteritis (EVA) outbreaks is being reported. This trend is likely to continue unless action is taken to slow or halt the transmission of this agent through semen.

Keywords: equine arteritis virus, prevention, control, review

References

  • 1.Balasuriya UBR, Rossitto P.V., DeMaula C.D., MacLachlan N.J. A 29K envelope glycoprotein of equine arteritis virus expresses neutralization determinants recognised by murine monoclonal antibodies. J Gen Virol. 1993;74:2525–2529. doi: 10.1099/0022-1317-74-11-2525. [DOI] [PubMed] [Google Scholar]
  • 2.Balasuriya UBR, MacLachlan N.J., de Vries AAF, Rossitto P.V., Rottier PJM. Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus. Virology. 1995;207:518–527. doi: 10.1006/viro.1995.1112. [DOI] [PubMed] [Google Scholar]
  • 3.Balasuriya UBR, Timoney P.J., McCollum W.H., MacLachlan N.J. Phylogenetic analysis of open reading frame 5 of field isolates of equine arteritis virus and identification of conserved and nonconserved regions in the GL envelope glycoprotein. Virology. 1995;214:690–697. doi: 10.1006/viro.1995.0087. [DOI] [PubMed] [Google Scholar]
  • 4.Belák S., Ballagi-Pordány A., Timoney P.J., McCollum W.H., Little T.V., Hyllseth B, Klingeborn B. Evaluation of a nested PCR assay for the detection of equine arteritis virus infection. In: Nakajima H, Plowright W, editors. Proceedings of the 7th International Conference on Equine Infectious Diseases; Tokyo, 1994; Newmarket: R&W Publications; 1994. pp. 33–38. [Google Scholar]
  • 5.Bergman A.M. Beiträge zur Kenntnis der Virusträger bei Rotlaufseuche, Influenza erysipelatosa, des Pferdes. Zentralbl Infektionskrankh. 1913;13:161–174. [Google Scholar]
  • 6.Bürki F, Gerber H. Ein virologisch gesicherter Groβausbruch von Equiner Arteritis. Berl Münch Tierärztl Wochenschr. 1966;79:391–395. [PubMed] [Google Scholar]
  • 7.Bürki F. The virology of equine arteritis virus. In: Bryans J.T., Gerber H, editors. Proceedings of the 2nd International Conference on Equine Infectious Diseases; Paris, 1969; Basel: Karger; 1970. pp. 125–129. [Google Scholar]
  • 8.Cancellotti F.M., Renzi M. Equine arteritis virus (EAV) in Italy: current situation. In: Plowright W, Rossdale P.D., Wade J.F., editors. Proceedings of the 6th International Conference on Equine Infectious Diseases; Cambridge, 1991; Newmarket: R&W Publications; 1992. p. 304. [Google Scholar]
  • 9.Carman S, Rae C, Dubovi E. Equine arteritis virus isolated from a standardbred foal with pneumonia. Can Vet J. 1988;29:937. [PMC free article] [PubMed] [Google Scholar]
  • 10.Cavanagh D, Brien D.A., Brinton M, Enjuanes L, Holmes K.V., Horzinek M.C., Lai MMC, Laude H, Plagemann PGW, Siddell S, Spaan WJM, Taguchi F, Talbot P.J. Revision of the taxonomy of the Coronavirus, Torovirus and Arterivirus genera. Arch Virol. 1994;135:227–237. doi: 10.1007/BF01309782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Chirnside E.D., Cook R.F., Lock M.W., Mumford J.A. Monoclonal antibodies to equine arteritis virus. In: Powell D.G., editor. Proceedings of the 5th International Conference on Equine Infectious Diseases; Lexington, 1987; Lexington: The University Press of Kentucky; 1988. pp. 262–267. [Google Scholar]
  • 12.Chirnside E.D., Spaan W.J.M. Reverse transcription and cDNA amplification by the polymerase chain reaction of equine arteritis virus (EAV) J Virol Meth. 1990;30:133–140. doi: 10.1016/0166-0934(90)90014-7. [DOI] [PubMed] [Google Scholar]
  • 13.Chirnside E.D., Wearing C.M., Binns M.M., Mumford J.A. Comparison of M and N gene sequences distinguishes variation amongst equine arteritis virus isolates. J Gen Virol. 1994;75:1491–1497. doi: 10.1099/0022-1317-75-6-1491. [DOI] [PubMed] [Google Scholar]
  • 14.Chirnside E.D., de Vries AAF, Mumford J.A., Rottier PJM. Equine arteritis virus-neutralizing antibody in the horse is induced by a determinant on the large envelope glycoprotein GL. J Gen Virol. 1995;76:1989–1998. doi: 10.1099/0022-1317-76-8-1989. [DOI] [PubMed] [Google Scholar]
  • 15.Chirnside E.D., Francis P.M., de Vries A.A.F., Sinclair R, Mumford J.A. Development and evaluation of an ELISA using recombinant fusion protein to detect the presence of host antibody to equine arteritis virus. J Virol Meth. 1995;54:1–13. doi: 10.1016/0166-0934(95)00020-U. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chirnside E.D., Francis P.M., Mumford J.A. Expression cloning and antigenic analysis of the nucleocapsid protein of equine arteritis virus. Virus Res. 1995;39:277–288. doi: 10.1016/0168-1702(95)00098-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Clark I. Transmission of pink-eye from apparently healthy stallions to mares. J Comp Path. 1892;5:261–264. [Google Scholar]
  • 18.Clayton H. 1986 outbreak of EVA in Alberta, Canada. J Equine Vet Sci. 1987;7:101. [Google Scholar]
  • 19.Coignoul F.L., Cheville N.F. Pathology of the maternal genital tract, placenta and foetus in equine viral arteritis. Vet Pathol. 1984;21:333–340. doi: 10.1177/030098588402100311. [DOI] [PubMed] [Google Scholar]
  • 20.Cole J.R., Hall R.F., Gosser H.S., Hendricks J.B., Pursell A.R., Senne D.A., Pearson J.E., Gibson C.A. Transmissibility and abortigenic effect of equine viral arteritis in mares. J Am Vet Med Assoc. 1986;189:769–771. [PubMed] [Google Scholar]
  • 21.Collins J.K., Kari S, Ralston S.L., Bennet D.G., Traub Dargatz J.L., McKinnon A.O. Equine viral arteritis in a veterinary teaching hospital. Prevent Vet Med. 1987;4:389–397. [Google Scholar]
  • 22.Cook R.F., Gann S.J., Mumford J.A. The effects of vaccination with tissue culture-derived viral vaccines on detection of antibodies to equine arteritis virus by enzyme-linked immunosorbent assay (ELISA) Vet Microbiol. 1989;20:181–189. doi: 10.1016/0378-1135(89)90041-2. [DOI] [PubMed] [Google Scholar]
  • 23.Crawford T.B., Henson J.B. Immunofluorescent, light-microscopic and immunologic studies of equine viral arteritis. In: Bryans J.T., Gerber H, editors. Proceedings of the 3rd International Conference on Equine Infectious Diseases; Paris, 1972; Basel: Karger; 1973. pp. 282–302. [Google Scholar]
  • 24.Del Piero F, Wilkins PA, Lopez J, Glaser A, Dubovi EJ, Schlafer DH, Lein D. Equine arteritis in newborn foals: clinical, pathological, serological, microbiological and immunoperoxidase histochemical findings. Submitted to Equine Vet J. [DOI] [PubMed]
  • 25.den Boon J.A., Snijder E.J., Chirnside E.D., de Vries A.A.F, Horzinek M.C., Spaan W.J.M. Equine arteritis virus is not a togavirus but belongs to the coronavirus-like superfamily. J Virol. 1991;65:2910–2920. doi: 10.1128/jvi.65.6.2910-2920.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.den Boon J.A., Faaberg K.S., Meulenberg J.J.M., Wassenaar A.L.M., Plagemann P.G.W., Gorbalenya A.E., Snijder E.J. Processing and evolution of the N-terminal region of the arterivirus replicase ORF1a protein: identification of two papainlike cysteine proteases. J Virol. 1995;69:4500–4505. doi: 10.1128/jvi.69.7.4500-4505.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Deregt D., de Vries A.A.F., Raamsman M.J.B., Elmgren L.D., Rottier P.J.M. Monoclonal antibodies to equine arteritis virus identify the GL protein as a target for virus neutralization. J Gen Virol. 1994;75:2439–2444. doi: 10.1099/0022-1317-75-9-2439. [DOI] [PubMed] [Google Scholar]
  • 28.de Vries A.A.F., Chirnside E.D., Bredenbeek P.J., Gravestein L.A., Horzinek M.C., Spaan W.J.M. All subgenomic mRNAs of equine arteritis virus contain a common leader sequence. Nucl Acids Res. 1990;18:3241–3247. doi: 10.1093/nar/18.11.3241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.de Vries A.A.F., Chirnside E.D., Horzinek M.C., Rottier P.J.M. Structural proteins of equine arteritis virus. J Virol. 1992;66:6294–6303. doi: 10.1128/jvi.66.11.6294-6303.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.de Vries A.A.F. Utrecht University; Utrecht: 1994. The molecular biology of equine arteritis virus. (Ph.D. thesis). [Google Scholar]
  • 31.Doll E.R., Bryans J.T., McCollum W.H., Crowe M. Isolation of a filterable agent causing arteritis of horses and abortion by mares. Its differentiation from the equine abortion (influenza) virus. Cornell Vet. 1957;47:3–41. [PubMed] [Google Scholar]
  • 32.Doll ER, Knappenberger RE, Bryans J.T. An outbreak of abortion caused by the equine arteritis virus. Cornell Vet. 1957;47:69–75. [PubMed] [Google Scholar]
  • 33.Doll ER, Bryans J.T., Wilson JC, McCollum W.H. Immunisation against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney. Cornell Vet. 1968;58:497–524. [PubMed] [Google Scholar]
  • 34.Eichhorn W, Heilmann M, Kaaden O-R. Equine viral arteritis with abortions: serological and virological evidence in Germany. J Vet Med Ser B. 1995;42:573–576. doi: 10.1111/j.1439-0450.1995.tb00750.x. [DOI] [PubMed] [Google Scholar]
  • 35.European Community Publication 1995;April 24:No. L 117/27
  • 36.Fukunaga Y, McCollum W.H. Complement fixation reactions in equine viral arteritis. Am J Vet Res. 1977;38:2043–2046. [PubMed] [Google Scholar]
  • 37.Fukunaga Y, Wada R, Hirasawa K, Kamada M, Kumanomido T, Akiyama Y. Effect of the modified Bucyrus strain of equine arteritis virus experimentally inoculated into horses. Bull Equine Res Inst. 1982;19:97–101. [Google Scholar]
  • 38.Fukunaga Y, Wada R, Kamada M, Kumanomido T, Akiyama Y. Tentative preparation of an inactivated virus vaccine for equine viral arteritis. Bull Equine Res Inst. 1984;21:56–64. [Google Scholar]
  • 39.Fukunaga Y, Wada R, Matsumura T, Sugiura T, Imagawa H. Induction of immune response and protection from equine viral arteritis (EVA) by formalin-inactivated virus vaccine for EVA in horses. J Vet Med Ser B. 1990;37:135–141. doi: 10.1111/j.1439-0450.1990.tb01036.x. [DOI] [PubMed] [Google Scholar]
  • 40.Fukunaga Y, Wada R, Matsumura T, Anzai T, Imagawa H, Sugiura T, Kumanomido T, Kanemaru T, Kamada M. An attempt to protect against persistent infection of equine viral arteritis in the reproductive tract of stallions using formalin-inactivated virus vaccine. In: Plowright W, Rossdale PD, Wade JF, editors. Proceedings of the 6th International Conference on Equine Infectious Diseases; Cambridge, 1991; Newmarket: R&W Publications; 1992. pp. 239–244. [Google Scholar]
  • 41.Fukunaga Y, Matsumura T, Sugiura T, Wada R, Imagawa H, Kanemaru T, Kamada M. Use of the serum neutralisation test for equine viral arteritis with different virus strains. Vet Rec. 1994;134:574–576. doi: 10.1136/vr.134.22.574. [DOI] [PubMed] [Google Scholar]
  • 42.Fukunaga Y, Wada R, Kanemaru T, Imagawa H. Failure in the development of carrier state of equine viral arteritis in colts. J Equine Sci. 1994;5:45–48. [Google Scholar]
  • 43.Fukunaga Y, Wada R, Kanemaru T, Imagawa H, Kamada M, Samejima T. Protection against abortion in pregnant mares vaccinated with a killed vaccine after exposure to equine arteritis virus. In: Nakajima H, Plowright W, editors. Proceedings of the 7th International Conference on Equine Infectious Diseases; Tokyo, 1994; Newmarket: R&W Publications; 1994. p. 340. [Google Scholar]
  • 44.Gerber H, Steck F, Hofer B, Walther L, Friedli U. Serological investigations on equine viral arteritis. In: Bryans J.T., Gerber H, editors. Proceedings of the 4th International Conference on Equine Infectious Diseases; Lyon, 1976; Princeton: Veterinary Publications Inc; 1978. pp. 461–465. [Google Scholar]
  • 45.Glaser A.L., de Vries AAF, Dubovi EJ. Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance. J Gen Virol. 1995;76:2223–2233. doi: 10.1099/0022-1317-76-9-2223. [DOI] [PubMed] [Google Scholar]
  • 46.Golnik W, Michalak T. Przypadki wirusowego zapalenia tetnic koni (arteritis equroum) w Polsce. Med Weterynaryjna. 1979;35:605–606. [Google Scholar]
  • 47.Golnik W, Michalska Z, Michalak T. Natural viral arteritis in foals. Schweiz Arch Tierheilk. 1981;123:523–533. [PubMed] [Google Scholar]
  • 48.Golnik W, Moraillon A, Golnik J. Identification and antigenic comparison of equine arteritis virus isolated from an outbreak of epidemic abortion of mares. J Vet Med Ser B. 1986;33:413–417. doi: 10.1111/j.1439-0450.1986.tb00051.x. [DOI] [PubMed] [Google Scholar]
  • 49.Golnik W. Viruses isolated from aborted foetuses and stillborn foals. In: Plowright W, Rossdale PD, Wade JF, editors. Proceedings of the 6th International Conference on Equine Infectious Diseases; Cambridge, 1991; Newmarket: R&W Publications; 1992. p. 314. [Google Scholar]
  • 50.Harry TO, McCollum W.H. Stability of viability and immunising potency of lyophilised, modified equine arteritis live virus vaccine. Am J Vet Res. 1981;42:1501–1505. [PubMed] [Google Scholar]
  • 51.Himeur D. Ecole Nationale Veterinaire d'Alfort; Maisons-Alfort: 1975. Incidence au maroc de l'anemie infectieuse, de la rhinopneumonie, de l'arterite a virus des equides — enquete epidemiologique — prophylaxie. (Ph.D. thesis). [Google Scholar]
  • 52.Holyoak GR, Little TV, McCollum W.H., Timoney PJ. Relationship between onset of puberty and establishment of persistent infection with equine arteritis virus in the experimentally infected colt. J Comp Path. 1993;109:29–46. doi: 10.1016/S0021-9975(08)80238-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Horzinek M.C. Academic Press; London: 1981. Non-arthropod-borne Togaviruses; pp. 30–31. [Google Scholar]
  • 54.Huntington PJ, Forman AJ, Ellis PM. The occurence of equine arteritis virus in Australia. Aust Vet J. 1990;67:432–435. doi: 10.1111/j.1751-0813.1990.tb03052.x. [DOI] [PubMed] [Google Scholar]
  • 55.Hyllseth B, Petersson U. Neutralisation of equine arteritis virus; enhancing effect of guinea pig serum. Arch Gesamte Virusforsch. 1970;32:337–347. doi: 10.1007/BF01250061. [DOI] [PubMed] [Google Scholar]
  • 56.Johnson B, Baldwin C, Timoney P, Ely R. Arteritis in equine fetuses aborted due to equine viral arteritis. Vet Pathol. 1991;28:248–250. doi: 10.1177/030098589102800310. [DOI] [PubMed] [Google Scholar]
  • 57.Klingeborn B, Wahlström H, Wierup M, Ballagi-Pordány A, Belák S. Prevalence of antibodies to equine arteritis virus in Sweden, shedding of the virus in semen from Swedish breeding stallions and evaluation of its possible influence on fertility. In: Plowright W, Rossdale PD, Wade JF, editors. Proceedings of the 6th International Conference on Equine Infectious Diseases; Cambridge, 1991; Newmarket: R&W Publications; 1991. pp. 319–320. [Google Scholar]
  • 58.Lang G, Mitchell WR. A serosurvey by ELISA for antibodies to EAV in Ontario racehorses. J Equine Vet Sci. 1984;4:153–157. [Google Scholar]
  • 59.Little TV, Holyoak GR, McCollum W.H., Timoney PJ. Output of equine arteritis virus from persistently infected stallions is testosterone-dependent. In: Plowright W, Rossdale PD, Wade JF, editors. Proceedings of the 6th International Conference on Equine Infectious Diseases; Cambridge, 1991; Newmarket: R&W Publications; 1992. pp. 225–229. [Google Scholar]
  • 60.Little TV, Deregt D, McCollum W.H., Timoney PJ. Evaluation of an immunohistochemical method for rapid detection and identification of equine arteritis virus in natural cases of infection. In: Nakajima H, Plowright W, editors. Proceedings of the 7th International Conference on Equine Infectious Diseases; Tokyo, 1994; Newmarket: R&W Publications; 1994. pp. 27–31. [Google Scholar]
  • 61.Lopez JW, Del Piero F, Glaser A, Finazzi M. Immunoperoxidase histochemistry as a diagnostic tool for detection of equine arteritis virus antigen in formalin fixed tissues. Equine Vet J. 1996;28:77–79. doi: 10.1111/j.2042-3306.1996.tb01593.x. [DOI] [PubMed] [Google Scholar]
  • 62.Magnusson P, Hyllseth B, Marusyk H. Morphological studies on equine arteritis virus. Arch Gesamte Virusforsch. 1970;30:105–112. doi: 10.1007/BF01250177. [DOI] [PubMed] [Google Scholar]
  • 63.Matumoto M, Shimizu T, Ishizaki R. Constat anticorps contre le virus de l'artérite équine dans le serum de juments indiennes. C R Soc Biol. 1965;159:1262–1264. [Google Scholar]
  • 64.McCollum W.H., Doll ER, Wilson JC, Johnson CB. Propagation of equine arteritis virus in monolayer cultures of equine kidney. Am J Vet Res. 1961;22:731–735. [Google Scholar]
  • 65.McCollum W.H., Doll ER, Wilson JC. The recovery of virus from horses with experimental cases of equine arteritis using monolayer cell cultures of equine kidney. Am J Vet Res. 1962;23:465–469. [Google Scholar]
  • 66.McCollum W.H. Development of a modified virus strain and vaccine for equine viral arteritis. J Am Vet Med Assoc. 1969;155:318–322. [PubMed] [Google Scholar]
  • 67.McCollum W.H. Vaccination for equine arteritis virus. In: Bryans J.T., Gerber H, editors. Proceedings of the 2nd International Conference on Equine Infectious Diseases; Paris, 1969; Basel: Karger; 1970. pp. 143–151. [Google Scholar]
  • 68.McCollum W.H., Prickett ME, Bryans J.T. Temporal distribution of equine arteritis virus in respiratory mucosa, tissues and body fluids of horses infected by inhalation. Res Vet Sci. 1971;12:459–464. [PubMed] [Google Scholar]
  • 69.McCollum W.H., Bryans J.T. Serological identification of infection by equine arteritis virus in horses of several countries. Proceedings of the 3rd International Conference on Equine Infectious Diseases; Paris, 1972; Basel: Karger; 1973. pp. 256–263. [Google Scholar]
  • 70.McCollum W.H. Studies of passive immunity in foals to equine viral arteritis. Vet Microbiol. 1976;1:45–54. [Google Scholar]
  • 71.McCollum W.H., Swerczek TW. Studies of an epizootic of equine viral arteritis in racehorses. Equine Vet J. 1978;2:293–299. [Google Scholar]
  • 72.McCollum W.H. Pathological features of horses given avirulent virus intramuscularly. Am J Vet Res. 1981;42:1218–1220. [PubMed] [Google Scholar]
  • 73.McCollum W.H., Timoney PJ. The pathogenic qualities of the 1984 strain of equine arteritis virus. Proceedings of the Grayson Foundation International Conference of Thoroughbred Breeders Organizations; Dromoland Castle; 1984. pp. 34–84. [Google Scholar]
  • 74.McCollum W.H. Responses of horses vaccinated with avirulent modified-live equine arteritis virus propagated in E. Derm (NBL-6) cell line to nasal inoculations with virulent virus. Am J Vet Res. 1986;47:1931–1934. [PubMed] [Google Scholar]
  • 75.McCollum W.H., Timoney PJ, Roberts AW, Willard JE, Carswell GD. Response of vaccinated and non-vaccinated mares to artificial insemination with semen from stallions persistently infected with equine arteritis virus. In: Powell DG, editor. Proceedings of the 5th International Conference on Equine Infectious Diseases; Lexington, 1987; Lexington: The University Press of Kentucky; 1988. pp. 13–18. [Google Scholar]
  • 76.McCollum W.H., Little TV, Timoney PJ, Swerczek TW. Resistance of castrated male horses to attempted establishment of the carrier state with equine arteritis virus. J Comp Path. 1994;111:383–388. doi: 10.1016/s0021-9975(05)80096-9. [DOI] [PubMed] [Google Scholar]
  • 77.McCollum W.H., Timoney PJ, Tengelson LA. Clinical, virological and serological responses of donkeys to intranasal inoculations with the KY-84 strain of equine arteritis virus. J Comp Path. 1995;112:207–211. doi: 10.1016/s0021-9975(05)80062-3. [DOI] [PubMed] [Google Scholar]
  • 78.McKinnon AO, Colbern GT, Collins JK, Bowen RA, Voss JL, Umphenour JW. Vaccination of stallions with a modified live equine arteritis virus vaccine. J Equine Vet Sci. 1986;6:66–69. [Google Scholar]
  • 79.Moraillon R, Moraillon A. Results of a serological survey of viral arteritis in France and several European and African countries. In: Bryans J.T., Gerber H, editors. Proceedings of the 4th International Conference on Equine Infectious Diseases; Lyon, 1976; Princeton: Veterinary Publications Inc; 1978. pp. 467–474. [Google Scholar]
  • 80.Moraillon A, Moraillon R, Toma B, Sedrati A, Lahlou-Kassi S. Enquête épidémiologique sur l'anémie infectieuse, la rhinopneumonie et l'artérite a virus des équidés au Maroc. Recl Méd Vét. 1978;154:921–928. [Google Scholar]
  • 81.Murphy FA. Togavirus morphology and morphogenesis. In: Schlesinger RW, editor. The Togaviruses: biology, structure and replication. Academic Press; New York: 1980. pp. 241–316. [Google Scholar]
  • 82.Neu SM, Timoney PJ, McCollum W.H. Persistent infection of the reproductive tract in stallions persistently infected with equine arteritis virus. In: Powell DG, editor. Proceedings of the 5th International Conference on Equine Infectious Diseases; Lexington, 1987; Lexington: The University Press of Kentucky; 1988. pp. 149–154. [Google Scholar]
  • 83.Neu SM, Timoney PJ, Lowry SR. Changes in semen quality in the stallion following experimental infection with equine arteritis virus. Theriogenology. 1992;37:407–431. [Google Scholar]
  • 84.Nowotny N. First isolation of equine arteritis virus (EAV) from three aborted equine foetuses from three different premises in Austria. In: Plowright W, Rossdale PD, Wade JF, editors. Proceedings of the 6th International Conference on Equine Infectious Diseases; Cambridge, 1991; Newmarket: R&W Publications; 1992. p. 328. [Google Scholar]
  • 85.Paweska J.T., Barnard BJH. Serological evidence of equine arteritis virus in donkeys in South Africa Onderstepoort. J Vet Res. 1993;60:155–158. [PubMed] [Google Scholar]
  • 86.Paweska J.T. An epidemiological investigation of equine viral arteritis in donkeys in South Africa. In: Nakajima H, Plowright W, editors. Proceedings of the 7th International Conference on Equine Infectious Diseases; Tokyo, 1994; Newmarket: R&W Publications; 1994. pp. 337–338. [Google Scholar]
  • 87.Paweska J.T. Equine viral arteritis. J S Afr Vet Assoc. 1995;66:111–112. [PubMed] [Google Scholar]
  • 88.Paweska J.T., Volkmann DH, Barnard BJH, Chirnside E.D. Sexual and in-contact transmission of asinine strain of equine arteritis virus among donkeys. J Clin Microbiol. 1995;33:3296–3299. doi: 10.1128/jcm.33.12.3296-3299.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Paweska J.T., Binns MM, Woods PSA, Chirnside ED. A survey for antibodies to equine arteritis virus in donkeys, mules and zebra using virus neutralisation (VN) and enzyme linked immunosorbent assay (ELISA). Submitted to Equine Vet J. [DOI] [PubMed]
  • 90.Porterfield JS, Casals J, Chumakov MP, Gaidamovich SYa, Hannoun C, Holmes IH, Horzinek M.C., Mussgay M, Oker-Blom N, Russel PK, Trent DW. Togaviridae. Intervirology. 1978;9:129–148. doi: 10.1159/000148930. [DOI] [PubMed] [Google Scholar]
  • 91.Pottie A. The propagation of influenza from stallions to mares. J. Comp Path. 1888;1:37–38. [Google Scholar]
  • 92.Sekiguchi K, Sugita S, Fukunaga Y, Kondo T, Wada R, Kamada M, Yamaguchi S. Detection of equine arteritis virus (EAV) by the polymerase chain reaction (PCR) and differentiation of EAV isolates by restriction enzyme analysis of PCR products. In: Nakajima H, Plowright W, editors. Proceedings of the Seventh International Conference on Equine Infectious Diseases; Tokyo, 1994; Newmarket: R&W Publications; 1994. p. 338. [Google Scholar]
  • 93.Senne DA, Pearson JE, Carbrey EA. Equine viral arteritis: a standard procedure for the virus neutralisation test and comparison of results of a proficiency test performed at five laboratories. Proceedings of the 89th Annual Meeting of the United States Animal Health Association; Milwaukee; 1985. pp. 29–34. [Google Scholar]
  • 94.Snijder EJ, Wassenaar A.L.M., Spaan WJM. The 5′ end of the equine arteritis virus replicase gene encodes a papainlike cysteine protease. J Virol. 1992;66:7040–7048. doi: 10.1128/jvi.66.12.7040-7048.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Snijder EJ, Wassenaar A.L.M., Spaan WJM, Gorbalenya AE. The arterivirus Nsp2 protease. An unusual cysteine protease with primary structure similarities to both papain-like and chymotrypsin-like proteases. J Biol Chem. 1995;270:16671–16676. doi: 10.1074/jbc.270.28.16671. [DOI] [PubMed] [Google Scholar]
  • 96.St-Laurent G, Morin G, Archambault D. Detection of equine arteritis virus following amplification of structural and nonstructural viral genes by reverse transcription-PCR. J Clin Microbiol. 1994;32:658–665. doi: 10.1128/jcm.32.3.658-665.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Sugita S, Kondo T, Sekiguchi K, Yamaguchi S, Kamada M, Nerome K, Fukunaga Y. Molecular evolution of the M gene of equine arteritis virus. In: Nakajima H, Plowright W, editors. Proceedings of the 7th International Conference on Equine Infectious Diseases; Tokyo, 1994; Newmarket: R&W Publications; 1994. pp. 39–43. [Google Scholar]
  • 98.Timoney PJ. Clinical, virological and epidemiological features of the 1984 outbreak of equine viral arteritis in the Thoroughbred population in Kentucky, USA. Proceedings of the Grayson Foundation International Conference of Thoroughbred Breeders Organizations; Dromoland Castle; 1984. pp. 24–33. [Google Scholar]
  • 99.Timoney PJ, McCollum W.H. Vol. 31. 1985. The epidemiology of equine arteritis virus; pp. 545–551. (Proc Am Assoc Equine Pract). [Google Scholar]
  • 100.Timoney PJ, McCollum W.H., Roberts AW, Murphy TW. Demonstration of the carrier state in naturally acquired equine arteritis virus infection in the stallion. Res Vet Sci. 1986;41:279–280. [PubMed] [Google Scholar]
  • 101.Timoney PJ, McCollum W.H., Murphy TW, Roberts AW, Willard AW, Carswell JG. The carrier state in equine arteritis virus infection in the stallion with specific emphasis on the venereal mode of transmission. J Reprod Fertil. 1987;35:95–102. (Suppl) [PubMed] [Google Scholar]
  • 102.Timoney PJ, McCollum W.H., Roberts AW, McDonald MJ. Status of equine arteritis virus in Kentucky, 1985. J Am Vet Med Assoc. 1987;191:36–39. [PubMed] [Google Scholar]
  • 103.Timoney PJ, McCollum W.H. Equine viral arteritis. epidemiology and control. J Equine Vet Sci. 1988;8:54–59. [Google Scholar]
  • 104.Timoney PJ, Umphenour NW, McCollum W.H. Safety evaluation of a commercial modified live equine arteritis virus vaccine for use in stallions. In: Powell DG, editor. Proceedings of the 5th International Conference on Equine Infectious Diseases; Lexington, 1987; Lexington: The University Press of Kentucky; 1988. pp. 19–27. [Google Scholar]
  • 105.Timoney PJ, McCollum W.H. Equine viral arteritis. Vet Clin North Am Equine Prac. 1993;9:295–309. doi: 10.1016/S0749-0739(17)30397-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Vaala WE, Hamir AN, Dubovi EJ, Timoney PJ, Ruiz B. Fatal, congenitally acquired infection with equine arteritis virus in a neonatal Thoroughbred. Equine Vet J. 1992;24:155–158. doi: 10.1111/j.2042-3306.1992.tb02803.x. [DOI] [PubMed] [Google Scholar]
  • 107.van Berlo MF, Horzinek M.C., van der Zeijst BAM. Equine arteritis virus-infected cells contain six polyadenylated virus-specific RNAs. Virology. 1982;118:345–352. doi: 10.1016/0042-6822(82)90354-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.van Berlo MF, Rottier PJM, Horzinek M.C., van der Zeijst BAM. Intracellular equine arteritis virus (EAV)-specific RNAs contain common sequences. Virology. 1986;152:492–496. doi: 10.1016/0042-6822(86)90154-6. [DOI] [PubMed] [Google Scholar]
  • 109.van Berlo MF, Rottier PJM, Spaan WJM, Horzinek M.C. Equine arteritis virus-induced polypeptide synthesis. J Gen Virol. 1986;67:1543–1549. doi: 10.1099/0022-1317-67-8-1543. [DOI] [PubMed] [Google Scholar]
  • 110.Wada R, Kondo T, Fukunaga Y, Kanemaru T. Histopathological and immunofluorescent studies on the uterus of aborted mares experimentally infected with equine arteritis virus. J Equine Sci. 1995;5:41–43. [Google Scholar]
  • 111.Weiss M, Ferrari L, Weibel-Attenberg P, Marti E, Burger D, Meier HP, Gerber H. Equine viral arteritis in Switzerland: a seroepidemiological survey. In: Nakajima H, Plowright W, editors. Proceedings of the 7th International Conference on Equine Infectious Diseases; Tokyo, 1994; Newmarket: R&W Publications; 1994. pp. 45–51. [Google Scholar]
  • 112.Westaway EG, Brinton MA, Gaidamovich SYa, Horzinek M.C., Igarashi A, Kääriäinen L, Lvov DK, Porterfield JS, Russell PK, Trent DW. Togaviridae. Intervirology. 1985;24:125–139. doi: 10.1159/000149632. [DOI] [PubMed] [Google Scholar]
  • 113.Westcott D, Lucas M, Paton D. Equine arteritis virus: antigenic analysis of strain variation. In: Schwyzer M, Ackermann M, Bertoni G, Kocherhans R, McCullough K, Engels M, Wittek R, Zanoni R, editors. Immunobiology of viral infections, Proceedings of the 3rd Congress of the European Society for Veterinary Virology; Interlaken, 1994; Lyon: Fondation Marcel Mérieux; 1995. pp. 479–483. [Google Scholar]
  • 114.Wood JLN, Chirnside E.D., Mumford JA, Higgins AJ. First recorded outbreak of equine viral arteritis in the United Kingdom. Vet Rec. 1995;136:381–385. doi: 10.1136/vr.136.15.381. [DOI] [PubMed] [Google Scholar]

Articles from Theriogenology are provided here courtesy of Elsevier

RESOURCES